Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Expert Opinion on Therapeutic Targets|June 17, 2008
Potential role of EPB41L3 (protein 4.1B/Dal-1) as a target for treatment of advanced prostate cancerDominic B Bernkopf, Elizabeth D Williams
Clinical & Experimental Metastasis|June 21, 2008
EMT and MET in carcinoma--clinical observations, regulatory pathways and new modelsErik W Thompson, Elizabeth D Williams
The International Journal of Biochemistry & Cell Biology|October 12, 2004
Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancerAnnet Hammacher, Erik W Thompson, Elizabeth D Williams
Cells, Tissues, Organs|November 6, 2010
Growth factors in induction of epithelial-mesenchymal transition and metastasisNur Akmarina B M Said, Elizabeth D Williams
Experimental Cell Research|August 16, 2011
Conserved signaling through vascular endothelial growth (VEGF) receptor family members in murine lymphatic endothelial cellsSanja Coso, Yiping Zeng, Dhanya Sooraj, et al.
Cells, Tissues, Organs|June 26, 2007
Mesenchymal to epithelial transition in development and diseaseChristine L Chaffer, Erik W Thompson, Elizabeth D Williams
Pain Medicine (Malden, Mass.)|October 20, 2012
Flupirtine enhances the anti-hyperalgesic effects of morphine in a rat model of prostate bone metastasisAnton Kolosov, Colin S Goodchild, Elizabeth D Williams, et al.
Pageof 10